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Abstract
The Fibromyalgia Survey Questionnaire (FSQ) assesses the key symptoms of fibromyalgia syndrome. The FSQ can be
administrated in survey research and settings where the use of interviews to evaluate the number of pain sites and extent of
somatic symptom intensity and tender point examination would be difficult. We validated the FSQ in a cross-sectional
survey with FMS patients. In a cross-sectional survey, participants with physician diagnosis of FMS were recruited by FMS-
self help organisations and nine clinical institutions of different levels of care. Participants answered the FSQ (composed by
the Widespread Pain Index [WPI] and the Somatic Severity Score [SSS]) assessing the Fibromyalgia Survey Diagnostic Criteria
(FSDC) and the Patient Health Questionnaire PHQ 4. American College of Rheumatology 1990 classification criteria were
assessed in a subgroup of participants. 1,651 persons diagnosed with FMS were included into analysis. The acceptance of
the FSQ-items ranged between 78.9 to 98.1% completed items. The internal consistency of the items of the SSS ranged
between 0.75–0.82. 85.5% of the study participants met the FSDC. The concordance rate of the FSDC and ACR 1990 criteria
was 72.7% in a subsample of 128 patients. The Pearson correlation of the SSS with the PHQ 4 depression score was 0.52
(p,0.0001) and with the PHQ anxiety score was 0.51 (p,0.0001) (convergent validity). 64/202 (31.7%) of the participants
not meeting the FSDC criteria and 152/1283 (11.8%) of the participants meeting the FSDC criteria reported an improvement
(slightly too very much better) in their health status since FMS-diagnosis (Chi
2=55, p,0.0001) (discriminant validity). The
study demonstrated the feasibility of the FSQ in a cross-sectional survey with FMS-patients. The reliability, convergent and
discriminant validity of the FSQ were good. Further validation studies of the FSQ in clinical and general population settings
are necessary.
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Introduction
The publication of American College of Rheumatology (ACR)
preliminary diagnostic criteria for fibromyalgia syndrome (FDC)
[1] eliminated the tender point examination required for the
clinical diagnosis of FMS by the ACR 1990 classification criteria
[2]. Because most of the ACR 2010 items can be obtained by self-
administration, the FDC were slightly modified so that complete
self-administration would be possible by the Fibromyalgia Survey
Diagnostic Criteria (FSDC). The FSDC were developed in a
longitudinal study of patients of the National Data Bank for
Rheumatic Diseases by substituting a count of three symptoms for
the physician’s (0–3) evaluation of the extent of somatic symptom
intensity by a questionnaire assessing the number of pain sites and
somatic symptom severity. Patients who satisfy FSDC meet the
following 3 conditions: 1) Widespread Pain Index (WPI) $7/19
pain sites and Symptom Severity Score (SSS) $5/12 or WPI
between 3–6/19 and SSS $9/12; 2) Symptoms have been present
at a similar level for at least 3 months; 3) The patient does not have
another disorder that would otherwise sufficiently explain the pain
[3]. The conditions 1 and 2 can be assessed by the Fibromyalgia
survey questionnaire (FSQ) including the WPI and SSS. The sum
of the WPI and the SSS constitutes the Fibromyalgianess Scale
(FS) or polysymptomatic distress scale as a measure of physical and
psychological symptom intensity (distress) which can be applied to
every disease. The FS can be used to track disease status. The
assessment of the key symptoms of FMS by the FSQ allows
administration in survey research and settings where the use of
interviews to evaluate the number of pain sites and extent of
somatic symptom intensity would be difficult.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37504In this study we provided the first translation of the FSQ into
German language and validated the FSQ for the first time in a
cross-sectional survey with FMS-patients in Germany.
Methods
Clinical institutions
Participants of the study were recruited by the two largest
German FMS-self help organisations and nine clinical institutions.
The specialties of the clinical institutions were pain medicine and
psychotherapy (N=3), rheumatology (N=2), complementary and
alternative medicine (N=2), physical therapy (N=1) and pain
therapy (N=1). The settings were outpatient (N=6), inpatient
(N=2) and day clinic (N=1). The levels of care were secondary
(N=6) and tertiary care (N=1) and rehabilitation (N=1).
From November 1, 2010 to April 30, 2011 all consecutive
patients with an established or first diagnosis of FMS of the
participating study centres were asked by the physicians of these
centres to take part in the study. All participating physicians had
more than 10 years exprerience in the management of FMS-
patients. The questionnaires were handed out by the physicians of
the centres with a standardized letter explaining the focus of the
study. The questionnaires were returned by the patients in a closed
and anonymous envelope and kept away from the charts. In 4
centres a tender point examination was performed according to a
standardised protocol [4].
Self-help organisations
The package of questionnaires was sent by the central office of
the German League for people with Arthritis and Rheumatism to
their regional offices with the request that the leaders of the local
self-help groups distribute the FSQ during the meetings to the
group members (FMS-patients). Group members were asked to fill
out the questionnaires separately outside the group meetings and
not to discuss it with other group members.
The German Fibromyalgia Association included the package in
the issue 4/2010 of its member journal ‘‘Optimist’’ dispatched by
post to all members.
The questionnaires were returned by the patients by post to the
central office. Moreover, the questionnaires were available on the
homepages of both self-help organisations. After downloading and
completing they could be sent by mail, fax or email to the central
offices. Employees of both central offices removed the personal
identifying information and sent the questionnaires to the
coordinating study centre.
Inclusion- and exclusion criteria
Members of the self-help organisations should report that the
diagnosis of FMS had been established by a physician. Participants
without (reported) physician diagnosis of FMS were excluded.
The patients of the study centres should have been previously or
currently diagnosed with FMS according to the ACR 1990
classification criteria [3] or the Association of the Medical
Scientific Societies in Germany (AWMF) criteria [5]. In four
study centres the ACR 1990 criteria (2) were reevaluated during
study examination. A diagnostic work-up including a complete
physical examination and defined laboratory tests according to the
German guideline on the management of FMS were performed in
every patient of the study centres in the past or during the study
[6]. Patients with somatic diseases sufficiently explaining the pain
sites of the WPI (e.g. highly active inflammatory rheumatic disease)
and patients who were not able to read German were excluded.
Questionnaires
Demographic data (age, sex, family status, educational level,
current professional status, member of a FMS-self help organisa-
tion) and medical data (Years since chronic widespread pain and
FMS-diagnosis] were assessed by a questionnaire used in a
previous multicenter FMS – study [5].
Patients were asked how their health status has changed over
the years since the diagnosis of FMS according to their opinion
(1=very much worse, 2=much worse, 3=slightly worse, 4=no
change, 5=slightly better, 6=much better, 7=very much better).
The FSQ included the Symptom Severity Score (SSS) with 3
major symptoms (fatigue, trouble thinking or remembering,
waking up tired [unrefreshed]) which can be coded 0–3 (0=not
present to 3=extreme) and three additional symptoms (Pain or
cramps in lower abdomen, depression, headache), which can be
coded to be present (1) or not present (0) (total suscore 0–3). These
three items are surrogates for somatic symptom burden item of the
ACR 2010 criteria (reference). The SSS ranges from 0–12. The
Widespread Pain Index (WPI) includes 19 non-articular pain sites
[2] (see table 1). The English version of the SSS had been forward
and backtranslated by four German physicians, two of whom had
worked for several years in the USA. We used the validated
German version of the WPI [7].
The 4-item Patient Health Questionnaire-4 (PHQ-4) is an ultra-
brief self-report questionnaire that consists of a 2-item depression
scale (PHQ-2) and a 2-item anxiety scale (GAD-2). A score of 3-or-
greater on the depression subscale represents a reasonable cut-
point for identifying potential cases of major depression or other
depressive disorder, a score of 3-or-greater on the anxiety subscale
represents a reasonable cut-point for generalized anxiety, panic,
social anxiety, and posttraumatic stress disorders. The PHQ 4 total
score can serve as measure for psychological distress [8]. We used
the validated German version of the PHQ 4 [9].
Validation methods and hypotheses
The methods used to validate the FSQ were as follows: Patient
acceptability (acceptance) of the FSQ was assessed by the
proportion of missing or invalid items. The proportion of missing
or invalid items should be approximately equal to those in surveys
of German patients with chronic liver diseases [10] and celiac
disease [11].The reliability of the SSS was assessed by internal
consistency (Cronbach’s a coefficient) which measures the overall
correlation between items within a scale. A level of 0.7 and higher
is considered desirable [12].Face (content) validity was assessed by
the think aloud technique [13] of five phycians (pain medicine,
psychosomatic medicine, rheumatology) and five FMS-patients of
local self-help groups not participating in the study who verbalized
their thoughts processes while filling out the FSQ.Convergent
validity of the SSS and FS was determined by the Pearson
correlation with the total sum score of the PHQ 4. The convergent
validity is fulfilled when the scale scores for related concepts show
moderate to high correlation (correlation coefficient 0.4 to 0.8)
[12].Convergent validity of the FSDC was determined by
comparing the concordance rates of self-reported diagnosis of
FMS made by a physician (members of self-help organisations)
with the FSDC and of physician - established diagnosis of FMS
(participants of clinical centres) with FSDC. Based on previous
studies of the concordance rates of different FMS-diagnostic
criteria [5,14] we expected concordance rates between 70–
80%.Discriminant validity was tested by the following hypothesis:
Longitudinal studies demonstrated that persons diagnosed with
FMS can switch between criteria positive and criteria negative
states [15]. Therefore we assumed, that patients who will not meet
Fibromyalgia Survey Questionnaire
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that their health status has improved since the diagnosis of FMS.
Statistical analysis
The data were entered by four pairs of study assistants into a
preconstructed excel-data sheet. The entering of data was checked
by two authors at random and on plausibility during descriptive
data analysis. Missing items of the SSS, WPI and PHQ 4 were
coded as zero. Patients were excluded from analysis if all items of
SSS and/or WPI and/or PHQ4 were not answered.
Support
The participants of the study did not receive any reimburse-
ment. Material costs were covered by the participating institutions.
Ethics
The requirements of data protection and medical professional
secrecy were respected by all study investigators. All participants
gave their informed written consent to the study. The study had
been specifically aproved by the ethical committee of the Ludwig
Maximilian Universita ¨t Mu ¨nchen and by the review boards of all
study centers.
Results
Study participants
There were no data available concerning how many patients
contacted by the self-help organisation did not meet the inclusion
criteria or refused to take part in the study. The German League
for people with Arthritis and Rheumatism estimated that
approximately 10 000 of their members were FMS-patients. The
German Fibromyalgia Association is reported to have approxi-
mately 4000 members with FMS.
123 patients of the clinical samples did not meet the primary
inclusion criteria and 40 of contacted patients refused to take part
in the study. 1694 persons returned the questionnaires, of which
1143 (69.2%) had been contacted via self-help organisations. 43 of
1694 contacted persons were excluded due to total missing items
in the WPI (N=40) or SSS (N=3). The questionnaires of at least
10 persons who were excluded due to missing WPI-items did not
include the WPI due to an organisational mistake. 1651 persons
were included into analysis.
The total study sample was composed of mainly middle-aged
women with a long duration of CWP and FMS-diagnosis. In 30
patients, FMS was diagnosed recently for the first time (see table 2).
881/1633 (54.6%) participants scored .=3 on the PHQ 4
Table 1. Fibromyalgia survey questionnaire.
I. Using the following scale, indicate for each item the
level of severity over the past week by checking the
appropriate box.
0: No problem
1: Slight or mild problems; generally mild or intermittent
2: Moderate; considerable problems; often present and/
or at a moderate level
3. Severe: continuous, life-disturbing problems
Fatigue % 0 % 1 % 2 % 3
Trouble thinking or remembering % 0 % 1 % 2 % 3
Waking up tired (unrefreshed) % 0 % 1 % 2 % 3
II. During the past 6 months have you had any of the
following symptoms?
Pain or cramps in lower abdomen % Yes % No
Depression % Yes % No
Headache % Yes % No
III. Joint/body pain
Please indicate below if you have had pain or tenderness
over the past 7 days in each of the areas listed below.
Please make an X in the box if you have had pain or
tenderness. Be sure to mark both right side and left side
separately
% Shoulder, left % Upper leg, left % Lower back
% Shoulder, right % Upper leg, right % Upper back
% Hip, left % Lower leg, left % Neck
% Hip, right % Lower leg, right
% Upper arm, left % Jaw, left % No pain in any of these areas
% Upper arm, right % Jaw, right
% Lower arm, left % Chest
% Lower arm, right % Abdomen
IV. Overall, were the symptoms listed in I–III above
generally present for at least 3 months?
% Yes % No
doi:10.1371/journal.pone.0037504.t001
Fibromyalgia Survey Questionnaire
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4 anxiety scale.
Validation
Acceptance. The participants included into analysis complet-
ed the SSS and PHQ 4 items as follows: Fatigue 1620 (98.1%),
trouble thinking 1609 (97.4%), waking up tired 1618 (98.0%), pain
in lower abdomen 1449 (87.8%), depression 1589 (96.2%),
headache 1303 (78.9%), three months duration of all symptoms
1375 (83.3%), loss of interest 1622 (98.2%), feeling down 1623
(98.3%), nervousness 1632 (98.8%), worries 1612 (97.6%).
Reliability (Internal consistency). Cronbach’s alpha of the
SSS was 0.65 and of the FS was 0.71.
Face validity. Two patients felt insecure where to indicate
pain in the elbows and knees in the WPI because these pain sites
were not mentioned. Two physicians felt puzzled by the different
time frames of the FSQ. One physician wondered why abdominal
pain was assessed both in the SSS and in the WPI.
Convergent validity. The Pearson correlation of the SSS
with the PHQ 4 total score was 0.56 (p,0.0001) and of the FS
with PHQ4 total score was 0.48 (p,0.001).
1411 (85.5%) participants of the total sample met the FSDC of
FMS. 1351 (95.7%) reported a WPI $7 and a SSS $5 and 60
(4.4%) reported a WPI 3–6 and a SSS $9.
The diagnosis of FMS according to the ACR 1990 criteria was
reevaluated at the date of appointment in 128 patients in 4 study
centres with previously or actually diagnosed FMS. The mean of
TPC was 13.8 (SD 3.5) (range 0–18). 107/128 (83.6%) partic-
ipants met the ACR 1990 classification criteria of FMS. The
concordance rate of the FSDC and ACR 1990 criteria was 72.7%
(see table 3).
Discriminant validity. 64/202 (31.7%) of the participants
not meeting the FSDC criteria and 152/1283 (11.8%) of the
participants meeting the FSDC criteria reported an improvement
(slightly too very much better) of their health status since FMS-
diagnosis (Chi
2=55, p,0.0001).
Discussion
Summary of main findings
In this study we provided the first translation of the FSQ into
another language and validated the FSQ for the first time in a
cross-sectional survey with 1651 FMS-patients. The acceptability,
reliability and validity of the FSQ met the predefined quality
criteria pointed out in the validation hypotheses.
Relation to other studies
The proportion of missing items in the SSS ranged from 1.9 to
21.1%. The item with 21% missing was the headache item. We
cannot explain the low completion rate of this item. The range was
higher than the one of a disease specific health-related question-
naire in a survey with 522 patients with celiac disease which was
0.2–11.2 [11] and with 202 chronic liver patients was 0.4–2.8%
[10].
The overall concordance rate of physician made diagnosis of
FMS and FSDC was 85.5%. In a subsample the concordance of
Table 2. Demographic and clinical characteristics of the total study sample.
Variable N Total Mean (SD), lowest and highest value N (%)
Sex female 1647 1562 (94.8)
Age 1644 54.1 (9.8), 19–84
Living with partner/in family 1641 1562 (77.4)
Educational level 1640
No school finished 27 (1.7)
Primary school 558 (34.0)
Secondary school 676 (41.2)
High school 131 (8.0)
University 248 (15.1)
Current professional status 1637
School 10 (0.6)
Working without sick leave 529 (31.1)
Working, sick leave 287 (14.9)
Applying for early retirement due to FMS 151 (8.9)
Without job 21 (1.2)
Homemaker 186 (10.9)
Pensioner 604 (35.6)
Member of a FMS self-help organisation 1640 994 (60.6)
Years since chronic widespread pain 1629 16.4 (11.6), 0.25–61
Years since FMS-diagnosis 1596 6.5 (5.5), 0–41
Somatic severity score (0–12) 1653 8.3 (2.6), 0–12
Widespread pain index (0–19) 1653 11.6 (3.2), 0–19
Fibromyalgianess Total score (0–31) 1650 19.9 (5.5); 5–31
Patient Health Questionnaire 4 Total score (0–12) 1652 6.0 (0.1), 0–12
doi:10.1371/journal.pone.0037504.t002
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rates were similar with the ones of a study in an US rheumatologic
practice in which the concordance rate of the ACR 1990 and
clinical criteria of FMS was 72% [14].
The study results highlight the problem of defining cut-off
values for continuous symptom disorders such as FMS. 14.5% of
the patients who had once been diagnosed with FMS did not meet
the FSDC criteria of FMS at the time of the survey. Most notably,
32% of these patients reported an improvement of health status
since FMS-diagnosis. In a longitudinal study with 1,555 fibromy-
algia patients meeting the FSDC citeria at study entry conversion
from and to criteria positive status was common during 7,448
semi-annual observations for up to 11 years. During follow-up 716
patients (44.0%) failed to meet criteria at least once, and at study
closure 24.3% failed to meet criteria [1]. In the long-term
management of these patients the assessment of the amount of
distress (‘‘fibromyalgianess’’ or polysymptomatic distress) is possi-
ble by summing the SSS and the WPI [3].
The study confirms the high levels of distress reported by FMS
patients and the concepualisation of FMS a continuum disorder
which can be located at the extreme end of the continuum of
distress [16,17].
Limitations
The study did not include FMS-patients from primary care
settings.
There is no gold standard how to deal with missing values. We
decided not to use imputation methods because the percentage of
missing values was one criterion of validation.
Testing of the test-retest reliability and responsiveness to change
was not possible within a cross-sectional survey. The test-retest
reliability of a WPI $7 in FMS-patients of different clinical
settings was 100% and the intraclass correlation of the WPI was
0.78 over a period of 4–12 weeks [7].
Because there is no gold standard of the clinical diagnosis of
FMS [18], the assessment of the criterion validity of the FSDC
were not possible. We used the ACR 1990 criteria as a common
standard for the assessment of convergent validity. Due to the
study design it was not possible to perform a TPC in all patients.
Conclusions
Research. The study demonstrated the feasibility, reliability
and validity of the FSQ in a survey with German FMS-patients.
Further validation studies of the FSQ in other countries and/or
languages are necessary. A standardization of the different time
frames of the questions of the FSQ should be considered.
Clinical practice. The FSDC are not be used for self-
diagnosis or as substitute for a physician’s diagnosis. The FSQ can
be used to gather information about the key symptoms of FMS
and the extent of somatic symptom reporting, but the interpre-
tation and assessment of questionnaire validity belongs to the
physician [19].
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